
Kennedy's Vaccine Panel Overhaul Sparks Expert Backlash and Safety Concerns
Jun 17, 2025 01:56 am UTC| Politics Health Governance
U.S. Health Secretary Robert F. Kennedy Jr.s recent dismissal of all 17 members of the CDCs Advisory Committee on Immunization Practices (ACIP) has triggered a strong backlash from vaccine experts. The ousted panelists...

Roche Halts Elevidys Dosing in Some Duchenne Patients After Fatalities
Jun 16, 2025 09:21 am UTC| Business Health
Roche (SIX:ROG) shares dropped 2% on Monday after the company paused dosing of its gene therapy Elevidys in non-ambulatory patients with Duchenne muscular dystrophy following two deaths caused by acute liver failure. In a...

RFK Jr. Shakes Up CDC Vaccine Panel Amid Political Tensions
Jun 14, 2025 00:45 am UTC| Politics Governance Health
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDCs Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members,...

FDA Delays KalVista’s Sebetralstat Decision Amid Workload Strain
Jun 14, 2025 00:36 am UTC| Governance Business Health
KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has extended its review of sebetralstat, an investigational treatment for hereditary angioedema (HAE), due to internal workload challenges...

FDA Expands Moderna’s RSV Vaccine Use to At-Risk Adults Aged 18–59
Jun 13, 2025 02:57 am UTC| Business Health
The U.S. Food and Drug Administration (FDA) has expanded the use of Modernas (NASDAQ:MRNA) RSV vaccine, mRESVIA, to adults aged 18 to 59 who are at increased risk of respiratory syncytial virus (RSV) disease. This marks...

Kennedy Appoints Vaccine Skeptics to CDC Panel, Reigniting Public Debate
Jun 12, 2025 11:21 am UTC| Politics Health Business
U.S. Health Secretary Robert F. Kennedy Jr. has named eight new members to the Centers for Disease Control and Preventions (CDC) Advisory Committee on Immunization Practices (ACIP), following the abrupt dismissal of all 17...

AstraZeneca’s Camizestrant Shows Major Breakthrough in Breast Cancer Treatment
Jun 02, 2025 00:06 am UTC| Business Health
AstraZenecas experimental pill camizestrant significantly reduced the risk of disease progression or death in hormone receptor-positive, HER2-negative breast cancer, according to new data presented at the American Society...